News and CommentHuman Genome Project

The Hunting of the SNP

See allHide authors and affiliations

Science  19 Dec 1997:
Vol. 278, Issue 5346, pp. 2047
DOI: 10.1126/science.278.5346.2047

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Company efforts to identify fine-scale variations in the human genome for drug development and other applications have galvanized a government plan to catalog these variations (see main text). Academics worry that private companies wielding new technologies for scanning the genome will lock up these "polymorphisms" in patent claims.